GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer (vol 16, pg 1, 2022)

被引：0
|
作者：
Bai, Xiaoyu
Li, Yue
Li, Yanlei
Li, Fan
Che, Na
Ni, Chusheng
Zhao, Nan
Zhao, Xiulan
Liu, Tieju
机构：
来源：
CLINICAL MEDICINE INSIGHTS-ONCOLOGY | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] GRHL2 expression functions in breast cancer aggressiveness and could serve as prognostic and diagnostic biomarker for breast cancer (vol 16, pg 1, 2022)
    Bai, Xiaoyu
    Li, Yue
    Li, Yanlei
    Li, Fan
    Che, Na
    Ni, Chunsheng
    Zhao, Nan
    Zhao, Xiulan
    Liu, Tieju
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [2] GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer
    Bai, Xiaoyu
    Li, Yue
    Li, Yanlei
    Li, Fan
    Che, Na
    Ni, Chunsheng
    Zhao, Nan
    Zhao, Xiulan
    Liu, Tieju
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [3] GRHL2 Expression Functions in Breast Cancer Aggressiveness and Could Serve as Prognostic and Diagnostic Biomarker for Breast Cancer
    Bai, Xiaoyu
    Li, Yue
    Li, Yanlei
    Li, Fan
    Che, Na
    Ni, Chunsheng
    Zhao, Nan
    Zhao, Xiulan
    Zhang, Yueyao
    Liu, Tieju
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [4] Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer
    Kwan, Edmond M.
    Fettke, Heidi
    Crumbaker, Megan
    Docanto, Maria M.
    To, Sarah Q.
    Bukczynska, Patricia
    Mant, Andrew
    Ng, Nicole
    Foroughi, Siavash
    Graham, Lisa-Jane K.
    Haynes, Anne-Maree
    Azer, Sarah
    Lim, Lisi Elizabeth
    Segelov, Eva
    Mahon, Kate
    Davis, Ian D.
    Parente, Phillip
    Pezaro, Carmel
    Todenhofer, Tilman
    Sathianathen, Niranjan
    Hauser, Christine
    Horvath, Lisa G.
    Joshua, Anthony M.
    Azad, Arun A.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (04)
  • [5] Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer
    Liu, Hui
    Bian, Qing-Zhao
    Zhang, Wei
    Cui, Hai-Bin
    ONCOLOGY LETTERS, 2022, 23 (01)
  • [6] CLINICAL UTILITY OF TENSIN 2 LEVELS AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN BREAST CANCER
    Serin, Kursat Rahmi
    Ucuncu, Zubeyr
    Temel, M. Kemal
    Bademler, Suleyman
    Soydinc, Hilal Oguz
    Karanlik, Hasan
    Karabulut, Senem
    ACTA MEDICA MEDITERRANEA, 2021, 37 (01): : 553 - 558
  • [7] PD-L1 protein expression is a prognostic biomarker in breast cancer
    Wimberly, H.
    Schalper, K.
    Chen, L.
    Velcheti, V.
    Pusztai, L.
    Rimm, D.
    CANCER RESEARCH, 2013, 73
  • [8] Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer
    Qu, Jingkun
    Zhao, Xixi
    Wang, Jizhao
    Liu, Chao
    Sun, Yuchen
    Cai, Hui
    Liu, Jianlin
    ONCOLOGY LETTERS, 2018, 15 (04) : 5236 - 5242
  • [9] SYCP2 expression is a novel prognostic biomarker in luminal A/B breast cancer
    Wu, Chihua
    Tuo, Youlin
    FUTURE ONCOLOGY, 2019, 15 (08) : 817 - 826
  • [10] PAIP2 is a potential diagnostic and prognostic biomarker of breast cancer and is associated with immune infiltration
    Wang, Chenyu
    Jiang, Xianglai
    Qi, Jiaojiao
    Xu, Jiachao
    Yang, Guangfei
    Mi, Chengrong
    FRONTIERS IN GENETICS, 2022, 13
12345